Skip to main content
Clinical Trials/KCT0004825
KCT0004825
Recruiting
未知

Multicenter and Prospective Clinical Study for the Development of Multi-Omics-Based Biomarkers in Acute Myeloid Leukemia

Chonnam National University Hospital Hwasun Hospital0 sites620 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Diseases of the blood and blood -forming organs and certain disorders involving the immune mechanism
Sponsor
Chonnam National University Hospital Hwasun Hospital
Enrollment
620
Status
Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
6 years ago
Study Type
Observational Study
Sex
All

Investigators

Sponsor
Chonnam National University Hospital Hwasun Hospital

Eligibility Criteria

Inclusion Criteria

  • Patients with newly diagnosed with acute myeloid leukemia by 4th edition of WHO criteria
  • 19 years of age or greater
  • Patients will receive intensive induction therapy
  • Female patients of childbearing potential must have negative pregnancy test results at entry.
  • Ability to understand the study objectives and willingness to sign written consent

Exclusion Criteria

  • Have other active malignancy
  • Pregnant of lactating women
  • Patients who have no desire to participate in the study
  • Isolated extramedullary myeloid sarcoma
  • Diagnosed with acute promyelocytic leukemia (APL) (FAB classification: M3\).

Outcomes

Primary Outcomes

Not specified

Similar Trials